SLGL · Sol-Gel Technologies Ltd. · Metrics
Market Cap
$214.45M
Shares
3.27M
Volume · Oct 28
25.64K
Avg daily vol (3M)
54.19K
SLGL metrics
65 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$68.18
Market cap
$214.45M
Price action
20 metricsPrice change (1W)
+3.6%
Price change (30D)
-1.8%
Price change (3M)
-17.9%
Price change (6M)
-3.8%
Price change (YTD)
+61.8%
Price change (1Y)
+71.3%
Trailing year
Price change (5Y)
—
52-week high
$97.97
52-week low
$30.64
Change from 52-week high
-30.4%
Change from 52-week low
+122.6%
Annualized volatility
84.0%
Annualized volatility (3M)
67.9%
Beta
0.8
RSI (14D)
48.4
Price vs SMA 50
-2.1%
Price vs SMA 200
-7.8%
Avg volume (3M)
54,616
Relative volume
0.7
Average dollar volume
$4.00M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
3.27M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
129.2×
reciprocal yield 0.8%
P / book
4.8
reciprocal yield 20.7%
FCF yield
-3.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.0%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
-987.0%
Trailing 12 months
Net margin
-910.1%
Gross profit (TTM)
—
Operating profit (TTM)
−$17.72M
Net income (TTM)
−$16.34M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-478.7%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-96.6%
Year over year
Net income growth YoY
-131.7%
Revenue (TTM)
$1.79M
Trailing 12 months
EPS growth YoY
-127.1%
Shares change YoY
+17.4%
Year over year · more shares
Revenue CAGR (3Y)
+70.9%
Revenue CAGR (5Y)
+17.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-34.0%
Return on assets
-30.4%
Debt / equity
—
Current ratio
10.4
EBITDA (TTM)
—
Free cash flow (TTM)
−$8.59M
Quick ratio
10.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$16.66M
Total assets
$53.76M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$8.54M
Capital expenditures (TTM)
$50,000
R&D (TTM)
$15.82M
SG&A (TTM)
—
Stock compensation (TTM)
$198,000
R&D / revenue
881.3%
Stock compensation / revenue
11.0%
Ownership (13F)
9 metrics13F filers
24
13F filer change QoQ
+3
Institutional ownership
40.4%
Conviction holders (share of 13F filers)
8.3%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+5.0%
Holder tenure
5.5
Price vs estimated holder cost
+35.0%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
4.2%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
50 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—